STEPS study
Recruiting
- Conditions
- Sarcoidosis, sarcoidose, prednisone, prednison, treatment, behandeling, pulmonary function, longfunctie
- Registration Number
- NL-OMON20636
- Lead Sponsor
- ErasmusMC
- Brief Summary
/a
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Patients with stage II/III sarcoidosis (based on a chest X-ray or equivalent on a CT-scan) (established using the criteria of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG));
Exclusion Criteria
- Previous immunosuppressive treatment for sarcoidosis (e.g. prednisone, methotrexate (MTX), Infliximab);
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Repeated measurements of the FVC and prednisone dose used<br>
- Secondary Outcome Measures
Name Time Method